IP Library Granted Patent US 11,284,621
Granted Patent B2
US 11,284,621 · App. 16/140,205 · Granted Mar 29, 2022

Compositions comprising peroxyacid and methods for producing and using the same

Inventors: Edwin D. Neas (Nunn, CO); John D. Skinner (Fort Collins, CO)
Assignee: ARMIS BIOPHARMA, INC.
A01N59/00A01N25/02A01N37/16A01N37/36A01N37/42A61K31/22A61K31/327A61K33/40A61K45/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,284,621
App. No.
16/140,205
Granted
Mar 29, 2022
Kind
B2
Abstract

The present invention provides methods for producing a non α-keto peracid that has lower toxicity and lower corrosivity. The present embodiments also provide methods and compositions for reducing microbes on a surface, methods, and compositions for preventing and reducing infectious vegetative bacteria on a substrate, and methods and compositions for treating a wound. In particular, compositions of the invention provide for a mixture of an α-keto peracid and a non α-keto peracid that works synergistically to reduce microbes on a surface, to prevent vegetative bacteria on a surface and to heal a wound in animals or humans.

Claims (14)

1. A composition consisting essentially of: a peroxyacid, a corresponding parent carboxylic acid of the peroxyacid, and an oxidizing agent,

wherein the ratio of oxidizing agent to carboxylic acid is from about 0.5:1 to about 6:1,

wherein the parent carboxylic acid is acetic acid in an amount of from 6.2 to about 120.4 mM, and the oxidizing agent is present in an amount of from about 7.2 to about 71.5 mM, and

wherein the composition is formulated for wound treatment as a topical gel, liquid, lotion, irrigation gel, spray, skin patch or application granules.

2. The composition of claim 1 , wherein the oxidizing agent is at least one agent selected from the group consisting of hydrogen peroxide, barium peroxide, sodium carbonate peroxide, calcium peroxide, sodium perborate, lithium peroxide, magnesium peroxide, strontium peroxide, zinc peroxide, potassium superoxide, and a combination thereof.

3. The composition of claim 2 , wherein the oxidizing agent is hydrogen peroxide.

4. The composition of claim 1 , wherein the ratio is 2:1.

5. A method of treating or healing a wound, comprising topically applying the composition of claim 1 to a wound on a subject.

6. The composition of claim 1 , further including peroxymaleic acid and maleic acid.

7. The composition according to claim 1 , wherein the composition further-includes at least one other peroxyacid.

8. The composition according to claim 7 , wherein the other peroxyacid is selected from the group consisting of peroxymaleic acid, peroxyformic acid and a combination thereof.

9. The composition according to claim 1 , wherein the composition is a wound healing composition.

10. The composition according to claim 1 , wherein the composition is deposited on or in the skin patch.

11. The composition according to claim 1 , wherein the wound is selected from the group consisting of a surgical wound, battle wound, accidental wound, thermal burn wound, chemical burn wound, chronic wound, decubitus ulcer, foot ulcer, venous ulcer, laser treatment wound, sunburn, an abrasion, and a combination thereof.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2022
From: NEAS, EDWIN D.; SKINNER, JOHN D.
To: CHD BIOSCIENCE, INC.
Reel/Frame 058804/0355 →
CHANGE OF NAME Recorded Jan 28, 2022
From: CHD BIOSCIENCE, INC.
To: ARMIS BIOPHARMA, INC.
Reel/Frame 058804/0931 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2022
From: NEAS, ED
To: ARMIS BIOPHARMA, INC.
Reel/Frame 058897/0929 →
Continuity (11)
Continuation 15865978 · Jan 9, 2018
Continuation 15403842 · Jan 11, 2017
Continuation 14058124 · Oct 18, 2013
Continuation 16140205
Continuation 15644646 · Jul 7, 2017
Continuation In Part 15223748 · Jul 29, 2016
Continuation 14671223 · Mar 27, 2015
Continuation 13898126 · May 20, 2013
Continuation 12760940 · Apr 15, 2010
Provisional Application 61715725 · Oct 18, 2012
Related Publication 20190021330A1 · Jan 24, 2019
Cited By (1)
US 12,702,655